Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 83

    Bayer to streamline structure of Management Board to cut costs

    Bayer to streamline structure of Management Board to cut costs

    Medical Dialogues Bureau12 Sept 2019 9:15 AM IST
    Bayer said last year it would lean more strongly on external firms and institutions for a better drug development pipeline, which most analysts regard...
    Purdue Pharma billion dollar OxyContin settlement would rank among largest in pharma history

    Purdue Pharma billion dollar OxyContin settlement would rank among largest in pharma history

    Medical Dialogues Bureau12 Sept 2019 9:00 AM IST
    Purdue Pharma's settlement could be valued at up to $12 billion, they said, which would make it the largest such settlement in U.S. pharmaceutical...
    Glenmark Pharma gets USFDA nod for generic version of Olux-E Foam to treat plaque psoriasis

    Glenmark Pharma gets USFDA nod for generic version of Olux-E Foam to treat plaque psoriasis

    Medical Dialogues Bureau11 Sept 2019 10:00 AM IST
    "Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Clobetasol Propionate...
    We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

    We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

    Medical Dialogues Bureau11 Sept 2019 9:30 AM IST
    "Passenger Vehicle Sales See Worst Ever Monthly Drop Since 1997-98 - we need measures that r not abt saving auto sector but abt saving 50% of...
    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Medical Dialogues Bureau11 Sept 2019 9:25 AM IST
    Dr Syed Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for...
    Novartis USD 2.1 million Zolgensma Data Issues: CEO Vas Narasimhan pledges to speed data integrity disclosures

    Novartis USD 2.1 million Zolgensma Data Issues: CEO Vas Narasimhan pledges to speed data integrity disclosures

    Medical Dialogues Bureau11 Sept 2019 9:15 AM IST
    In August, Novartis said it knew about discrepancies in data it had submitted to regulators as it sought approval of Zolgensma, but delayed notifying...
    USFDA warns Juul over unproven claims that e-cigarette is safer than smoking

    USFDA warns Juul over unproven claims that e-cigarette is safer than smoking

    Medical Dialogues Bureau11 Sept 2019 9:00 AM IST
    In a sternly worded warning letter, the agency flagged various claims made by Juul representatives, including that its products are "much safer than...
    Sun Pharma arm fully acquires PJSC Biosintez after buying 3.04 pc remaining stake for Rs 6 crore

    Sun Pharma arm fully acquires PJSC Biosintez after buying 3.04 pc remaining stake for Rs 6 crore

    Medical Dialogues Bureau10 Sept 2019 10:00 AM IST
    Cash consideration of Rubles 54,194,628.60 equivalent to USD 815,201.99 (about Rs 6 crore) was paid to shareholders who tendered their respective...
    Lupin gets USFDA nod for generic version of Edecrin tablets to treat Edema in US

    Lupin gets USFDA nod for generic version of Edecrin tablets to treat Edema in US

    Medical Dialogues Bureau10 Sept 2019 9:45 AM IST
    Lupin has received US Food and Drug Administration (USFDA) approval for Ethacrynic Acid tablets, a generic version of Bausch Health's Edecrin tablets,...
    India, China to cooperate in RnD for promoting Indian generic drugs, Chinese APIs

    India, China to cooperate in RnD for promoting Indian generic drugs, Chinese APIs

    Medical Dialogues Bureau10 Sept 2019 9:30 AM IST
    The working group on pharmaceuticals decided that both sides should explore cooperation for promoting Indian generic drugs and Chinese APIs (raw...
    Eli Lilly drug Selpercatinib shrinks tumours in lung cancer trial

    Eli Lilly drug Selpercatinib shrinks tumours in lung cancer trial

    Medical Dialogues Bureau10 Sept 2019 9:15 AM IST
    Eli Lilly's drug, now called selpercatinib, is intended for patients with rare RET abnormalities, which occur in about 2% of non-small cell lung...
    Axon Neuroscience indicates tentative Alzheimers drug hope

    Axon Neuroscience indicates tentative Alzheimers drug hope

    Medical Dialogues Bureau10 Sept 2019 9:00 AM IST
    Axon Neuroscience said its AADvac1 drug, which targets pathological changes in the brain to the so-called tau protein that is a hallmark of the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok